Physician profile
Edgar Emeric
NPI 1619978566
$2,771.52
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,777 · 2020: $177 · 2021: $490 · 2024: $207 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $711.71 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $424.50 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.23 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $266.44 | 2019-2024 | Farxiga |
| Lilly USA, LLC | $247.91 | 2019-2024 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $181.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $120.12 | 2019 | |
| Merck Sharp & Dohme LLC | $108.91 | 2019 | |
| Astellas Pharma US INC | $76.95 | 2019 | |
| Novo Nordisk INC | $74.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.24 | 2019 | |
| Daiichi Sankyo INC. | $41.03 | 2019 | |
| Pfizer INC. | $27.46 | 2019-2021 | |
| Mylan Specialty L.P. | $23.45 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.37 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.98 | 2019 | |
| Allergan, INC. | $20.67 | 2020 | |
| Glaxosmithkline, LLC. | $18.66 | 2019 | |
| Medtronic Vascular, INC. | $14.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Emeric listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.